Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplastic Syndromes, Hereditary 1Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 7Cisplatin 6durvalumab 5pembrolizumab 4gemcitabine-oxaliplatin regimen 3S 1 (combination) 3Carboplatin 3Trastuzumab 2Paclitaxel 2Capecitabine 2tucatinib 1tremelimumab 1merestinib 1irinotecan sucrosofate 1envafolimab 1Tegafur 1Ramucirumab 1Radiation 1Psilocybin 1Poly(ADP-ribose) Polymerase Inhibitors 1Pemetrexed 1Oxaliplatin 1Nivolumab 1Leucovorin 1Itraconazole 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1Fulvestrant 1Fluorouracil 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Biliary Tract Neoplasms × High-Throughput Nucleotide Sequencing × Clear all
NCT05036486 2026-01-20

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

National Health Research Institutes, Taiwan

Active not recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡